학술논문
Vosoritide therapy in children with achondroplasia aged 3−59 months: a multinational, randomised, double-blind, placebo-controlled, phase 2 trial
Document Type
Article
Author
Savarirayan, Ravi ; Wilcox, William R; Harmatz, Paul; Phillips, John, III; Polgreen, Lynda E; Tofts, Louise; Ozono, Keiichi; Arundel, Paul; Irving, Melita; Bacino, Carlos A; Basel, Donald; Bober, Michael B; Charrow, Joel; Mochizuki, Hiroshi; Kotani, Yumiko; Saal, Howard M; Army, Clare; Jeha, George; Qi, Yulan; Han, Lynn; Fisheleva, Elena; Huntsman-Labed, Alice; Day, Jonathan
Source
In The Lancet Child & Adolescent Health January 2024 8(1):40-50
Subject
Language
ISSN
2352-4642